Abstract
For decades, digoxin has been widely used to control ventricular rate in atrial fibrillation (AF). However, it remains controversial as to whether digoxin is associated with increased mortality in AF. In this study, we searched relevant studies that were published before December 1, 2014, in PubMed, EMBASE, and the Cochrane central databases. We systematically reviewed the references and performed a meta-analysis of 8 carefully selected studies with 302,738 patients who were included for the final analysis. It was shown that digoxin use was associated with increased risk of all-cause mortality in AF overall [hazard ratio (HR) = 1.375, 95% confidence intervals (CI), 1.201-1.574, P = 0.0001]. Subgroup analysis further revealed that digoxin was associated with increased all-cause mortality in patients with AF, which was complicated by heart failure (HF) (HR = 1.201, CI, 1.074- 1.344, P = 0.001), and in those subjects without HF (HR = 1.172, CI, 1.148-1.198, P = 0.0001). Sensitivity analyses found results to be robust. Our findings indicated that digoxin use was associated with significantly increased all-cause mortality in patients with AF regardless of concomitant HF. We suggest that digoxin should not be preferentially used over...Continue Reading
References
Nov 1, 1991·Circulation·M Gheorghiade, D Ferguson
Jan 1, 1986·Circulation·S YusufC Furberg
May 1, 1993·Postgraduate Medical Journal·G Y LipF G Dunn
Oct 1, 1993·Journal of the American College of Cardiology·R A Kelly, T W Smith
Oct 6, 1997·BMJ : British Medical Journal·M EggerC Minder
Jun 2, 1998·Cardiovascular Drugs and Therapy·P E VardasG I Chlouverakis
Jan 28, 1999·Statistics in Medicine·M K ParmarL Stewart
Mar 9, 1999·Circulation·P J Hauptman, R A Kelly
Nov 19, 2002·Statistics in Medicine·Oliver N Keene
Jun 24, 2004·Circulation·Mihai GheorghiadeWilson S Colucci
Dec 16, 2004·Psychological Methods·Daniel F McCaffreyAndrew R Morral
Apr 21, 2005·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Julio A ChirinosYeon S Ahn
May 8, 2007·Heart·K GjesdalS B Olsson
Aug 9, 2007·European Journal of Clinical Pharmacology·Pär HallbergUNKNOWN RIKS-HIA group
Jan 6, 2009·The American Journal of Cardiology·Laurent FauchierBernard Charbonnier
Aug 28, 2009·Heart·L FribergM Rosenqvist
Aug 31, 2010·European Heart Journal·A John CammFrans H Rutten
Mar 27, 2012·The American Journal of Medicine·Eric H YangJohn M Criley
Nov 29, 2012·European Heart Journal·Matthew G WhitbeckClaude S Elayi
Apr 18, 2013·European Heart Journal·Mihai GheorghiadeAli Ahmed
Jan 1, 2014·International Journal of Cardiology·Nileshkumar J PatelRaul D Mitrani
Jun 22, 2014·The American Journal of Cardiology·Mitesh ShahLouise Pilote
Aug 16, 2014·Journal of the American College of Cardiology·Mintu P TurakhiaPaul A Heidenreich
Sep 30, 2014·The Canadian Journal of Cardiology·Tze-Fan ChaoShih-Ann Chen
Nov 22, 2014·Circulation. Arrhythmia and Electrophysiology·James V FreemanAlan S Go
Citations
Apr 7, 2017·Systematic Reviews·Naqash J SethiJanus C Jakobsen
Apr 14, 2016·Journal of Pharmacy Practice·Michael J Scalese, Dominick J Salvatore
Apr 17, 2018·Pacing and Clinical Electrophysiology : PACE·Richard CharnigoClaude S Elayi
Apr 20, 2018·Journal of Cardiovascular Pharmacology·Hua QiangZhi-Quan Wang
Aug 2, 2018·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Thomas F Whayne
Mar 9, 2018·PloS One·Naqash J SethiJanus C Jakobsen
Jun 27, 2019·Current Cardiology Reviews·Filipe FerrariRicardo Stein
Feb 6, 2021·Pharmacotherapy·William L BakerRobert J DiDomenico
Jun 5, 2021·International Journal of Cardiology·Niklas BodeLars Eckardt
Jul 1, 2021·International Journal of Clinical Practice·Taomin SuDongfeng Guo
Oct 19, 2021·Frontiers in Cardiovascular Medicine·Xiaoxu WangKun Zhao
Nov 3, 2021·International Journal of Immunopathology and Pharmacology·Ciprian Ilie RoscaDaniel Florin Lighezan
Nov 9, 2021·Cardiovascular Drugs and Therapy·J TriskaY Birnbaum
Oct 20, 2021·European Heart Journal. Cardiovascular Pharmacotherapy·Wern Yew DingGregory Y H Lip